Getinge AB
STO:GETI B
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
165.35
239.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one GETI B stock under the Base Case scenario is 266.23 SEK. Compared to the current market price of 168 SEK, Getinge AB is Undervalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Getinge AB
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for GETI B cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Getinge AB
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Getinge AB
Balance Sheet Decomposition
Getinge AB
Current Assets | 16.3B |
Cash & Short-Term Investments | 2.2B |
Receivables | 6.8B |
Other Current Assets | 7.3B |
Non-Current Assets | 43.3B |
Long-Term Investments | 33m |
PP&E | 5.5B |
Intangibles | 36.8B |
Other Non-Current Assets | 952m |
Current Liabilities | 15.2B |
Accounts Payable | 2.1B |
Other Current Liabilities | 13.1B |
Non-Current Liabilities | 14.1B |
Long-Term Debt | 7.2B |
Other Non-Current Liabilities | 6.9B |
Earnings Waterfall
Getinge AB
Revenue
|
33.6B
SEK
|
Cost of Revenue
|
-18.2B
SEK
|
Gross Profit
|
15.4B
SEK
|
Operating Expenses
|
-12.1B
SEK
|
Operating Income
|
3.2B
SEK
|
Other Expenses
|
-1.5B
SEK
|
Net Income
|
1.7B
SEK
|
Free Cash Flow Analysis
Getinge AB
SEK | |
Free Cash Flow | SEK |
In Q3, Getinge enjoyed a remarkable 10% growth in order intake, with 7.4% attributed to organic growth, primarily driven by increases in acute care therapies. However, net sales rose only 3.5%, showing flat organic growth. Adjusted gross margins were impacted, particularly in Acute Care Therapies, where they decreased by 5.6 percentage points. Despite this, the company anticipates organic net sales growth of 2% to 5% for 2024 and integration of recent acquisitions to contribute an additional 3% to 5%. Getinge's financial position remains robust, with a focus on resolving supply chain issues and enhancing productivity.
What is Earnings Call?
GETI B Profitability Score
Profitability Due Diligence
Getinge AB's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Getinge AB's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
GETI B Solvency Score
Solvency Due Diligence
Getinge AB's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Score
Getinge AB's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GETI B Price Targets Summary
Getinge AB
Dividends
Current shareholder yield for GETI B is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
GETI B Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 10,729 full-time employees. The firm provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Contact
IPO
Employees
Officers
The intrinsic value of one GETI B stock under the Base Case scenario is 266.23 SEK.
Compared to the current market price of 168 SEK, Getinge AB is Undervalued by 37%.